The tumor microenvironment (TME), characterized mainly by the distribution of tumor-infiltrating lymphocytes (TILs) in peritumoral regions, correlates with PD-L1 expression by the tumor and immune cells and therefore predicts the response to immunotherapy [52,53]. This evidence concerns the gene CD274 and neoplasm.